← Open Payments lookup

KATHERINE MAHDAVI: Open Payments

NPI 1972379758 · ANNAPOLIS, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,062 in 76 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,399 · 2025 $2,062

Food & beverage: $1,882Education: $180
CompanyPaymentsAmount
Janssen Biotech, Inc.11$407
GENZYME CORPORATION10$327
ABBVIE INC.14$288
Novartis Pharmaceuticals Corporation8$168
Amgen Inc.5$98
Boehringer Ingelheim Pharmaceuticals, Inc.3$97
SANOFI-AVENTIS U.S. LLC1$97
Incyte Corporation4$94
SUN PHARMACEUTICAL INDUSTRIES INC.2$65
Organogenesis Inc.1$60

Products named: DUPIXENT, TREMFYA, SKYRIZI, COSENTYX, OTEZLA, SPEVIGO, OPZELURA, ILUMYA.

Industry payments across MD — which companies pay providers there.